"Report Uncovers Key Trends, Disease Insights and Clinical Trials Shaping the Future of the Global mRNA Therapeutics Market"Boston, Oct. 29, 2025 (GLOBE NEWSWIRE) -- According to the latest study from ...

The same Nobel-winning mRNA technology that helped curb the Covid-19 pandemic may be poised to transform cancer care.

In earlier laboratory experiments, researchers had observed that mRNA vaccines improve the effectiveness of cancer drugs such ...

Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing ...

Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...

NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...

Moderna (MRNA), with its widely used COVID-19 vaccine, rose to prominence during the global pandemic. The stock soared an eye ...

Venture financing for messenger ribonucleic acid (mRNA)-based innovator vaccines declined by 82% from $510m in 2023 to $90m in the 2025's year to date (YTD), according to GlobalData’s Pharma ...

WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and ...

A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua ...